Charité Universitätsmedizin Berlin Campus Buch

Berlin 10117

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Systemic Lupus Erythematosus

Studies at this site

• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis — Completed
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus — Stopped early